Thesis (Ph. D.)--University of California, San Diego, 2001. / Vita. Accompanying videorecording (14 min. : sd., col. ; 1/2 in.) has title: Barbasco, la raíz de la discordia. Includes bibliographical references (leaves 248-266).

No description available.

Thesis (M.B.A.)--Boston University

Diss. Stockholm : Handelshögsk., 2001.

Thesis (Ph.D.)--University of Wisconsin-Madison, 1985. / Description based on print version record. Includes bibliographical references (leaves 396-426).

Diss. Linköping : Linköpings universitet, 2005.

nÃo hà / Neste estudo percorreu-se rapidamente a histÃria recente da indÃstria farmacÃutica brasileira para poder-se ocupar da observaÃÃo de sua conjuntura atual no que se refere à Pesquisa & Desenvolvimento, tendo a InovaÃÃo como foco principal e o suporte das estruturas de Marketing como propulsoras de sua expansÃo. Foram estudados artigos, revistas, entrevistas, grÃficos, estatÃsticas e avaliaÃÃes levadas a pÃblico ao longo dos Ãltimos seis anos, nos diversos meios de comunicaÃÃo escrita do Brasil, acerca do panorama geral da indÃstria farmacÃutica brasileira e mundial. Buscou-se interpretar as tendÃncias atuais de administraÃÃo interna das empresas, avaliando-se a reaÃÃo da indÃstria farmacÃutica nacional frente Ãs fusÃes entre as multinacionais, formando grandes conglomerados farmacÃuticos. Buscou-se tambÃm estabelecer a importÃncia da legislaÃÃo e farmacovigilÃncia nacionais, nÃo sà a partir de seu papel normativo, mas tambÃm seu papel fiscalizador. A acirrada convivÃncia dos mercados e instituiÃÃes transnacionais obriga as naÃÃes a desenvolverem estratÃgias personalizadas, mas que representem potenciais interesses do consumo mundial. No Brasil, a biodiversidade Ãnica no planeta à a principal chave para o desenvolvimento da indÃstria farmoquÃmica nacional e, para que se possa competir internacionalmente, a cadeia produtiva do setor, necessita defender algumas causas prioritÃrias para o equacionamento da questÃo, como a âPropriedade Intelectualâ, pois sem um sistema legal que garanta o retorno dos gigantescos recursos aplicados na criaÃÃo de novos produtos e no financiamento da estrutura de Pesquisa & Desenvolvimento haverà pouca ou nenhuma chance de marcar e expandir a presenÃa com substÃncias genuinamente brasileiras mundo afora. Para que a biodiversidade de nosso territÃrio possa transformar-se em sinÃnimo de saÃde e divisas ao povo, aos laboratÃrios e cofres brasileiros, alÃm de aprimorar o sistema legal que envolve a cadeia produtiva dos farmoquÃmicos necessita-se tambÃm, vislumbrar sobre as metodologias para o estabelecimento de parcerias com a Universidade, atravÃs da difusÃo da âSistematizaÃÃo da Pesquisa & Desenvolvimento voltada para LaboratÃrios FarmacÃuticos e a consequente ImplantaÃÃo e GestÃo de seus Sistemas de Qualidade: os caminhos a serem seguidos para integrar e atingir a expansÃo desse mercadoâ / In this investigation, we briefly evaluated the recent history of Brazilian Pharmaceutical Industry to examine the actual insight of its Research and Development, considering the innovation as its primary focus and the support of its Marketing networks primarily functioning as propeller for its growth. We critically evaluated published articles, periodicals, interviews, graphs including statistical data, and reports that were published in the past 6 years in numerous Brazilian publications concerning Brazilian and World Pharmaceutical Industry. We considered the actual tendencies of the pharmaceutical industry, i.e., a companyâs internal administration, evaluating the response of the national pharmaceutical industry to the consolidation of multinationals companies resulting in large pharmaceutical conglomerates. In addition, we attempted to establish the influence of the national legislation including Pharmacosurveillance, not only considering their normative function, but also its fiscal control. The strong relation, if not association, between the markets and international institutions force the nations to develop their own strategies that comply with the potential interest as it relates to worldwide consumption. Brazil, recognized as the single biodiversity on the planet is the main key for the national pharmaceutical and chemical industry development. When one looks for an advantage in international competition, it is necessary to assess some priorities in the production chain such as the issue of Intellectual Property, among others, since without a legal system that assures the returns on extraordinary funds invested in new products development as well as to finance the machinery of the Research & Development Departments; we will have limited or no chance to be present and to grow worldwide with genuine Brazilian substances/products. Additionally, in order to transform our biodiversity in health and exchange value to our people, laboratories, and to the Brazilian investment (funds), besides the refinement of the legal system that involves the pharmaceuticals and chemicals production chain, we need to acquire methodologies to establish University-Industry partnerships through the diffusion of the: âSystematization of Research & Development applied to pharmaceutical companies and the consequent Implantation and management of their Quality Systems: the steps to be followed to integrate and grow in this marketâ

Thesis (M.A.)--University of Waterloo, 1994. / Includes bibliographical references (p. 131-142).

Thesis (M.A.)--University of Waterloo, 1994. / Includes bibliographical references (p. 131-142).

Thesis (Ph.D.) - University of KwaZulu-Natal, Pietermaritzburg, 2009. / Full text also available online. Scroll down for electronic link.